German generic manufacturer in Berlin-Reinickendorf, part of the Aristo Pharma Group, producing over 1.5 billion tablets and capsules a year such as proton pump inhibitors, statins and antidepressants; Aristo announced the site's closure in 2026.
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen